Purdue exec agreed to hide OxyContin strength from doctors

According to reports, Purdue executive Richard Sackler agreed to withhold the potency of the opioid analgesic OxyContin from doctors, The Hill reported.

Using emails from a sealed deposition, the reports alleged that Sackler to a suggestion by sales and marketing director Michael Friedman to not contest the belief that OxyContin was less potent than morphine.

Sackler is a member of the controlling family of the drugmaker.

In 2007, Purdue paid $600 million in fines after pleading guilty to downplaying OxyContin's potency.

"During the deposition, [Sackler] described Purdue’s efforts to adhere to all relevant laws and regulations," commented Purdue Pharma spokesperson Bob Josephson.

Register as Visitor to CPhI China 2019!